A2A Pharma Competitors and Similar CompaniesClear all
Immunai's competitors and similar companies include CSL Behring and Biogen.
 Immunai Immunai is a biotechnology company specializing in immune cell data analysis for drug development. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ||
Founding Date | Founding Date 2018 | Founding Date 1904 | Founding Date 1978 |
Type | Type Private | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations New York, US HQ Prague, CZ Ness Ziona, IL Tel Aviv, IL Zurich, CH | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 1873% increase | Employees 7,5692% decrease | Employees 7,605 |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) 26.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) |
Operating ⚠ | |||
Trademark Applications | Trademark Applications 3 (Feb, 2021) | Trademark Applications 1 (Dec, 2020) | Trademark Applications N/A |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company